Pharmacy Podcast Network

In this relaunch of the PBM Reform Podcast, Greg Reybold returns with a powerful and timely conversation exploring how concentrated economic power—particularly in the form of Pharmacy Benefit Managers (PBMs)—is undermining fair access to prescription medications, driving up drug costs, and crushing independent pharmacies. Greg is joined by Emma Freer, Senior Policy Analyst with the American Economic Liberties Project, a national non-profit and non-partisan organization dedicated to dismantling monopolistic control across critical sectors—including healthcare. Together, they dig deep into how PBMs serve as gatekeepers in the drug supply chain, extracting value at the expense of patients and providers, and how policy reform is urgently needed. Emma outlines how Economic Liberties is driving a new wave of anti-monopoly policy momentum in healthcare by advocating for stronger antitrust enforcement, corporate accountability, and legislative transparency. She highlights how concentrated PBM power not only threatens economic fairness but undermines public health outcomes. 🧠 Key Topics Covered: The history and unchecked growth of PBM power in the U.S. drug supply chain Why market concentration among PBMs is a systemic risk to patient access and competition What Economic Liberties is doing to pressure regulators and lawmakers for structural reforms Why bipartisan PBM reform is gaining traction—and what’s at stake if we fail to act How pharmacists, community leaders, and patients can join the movement for transparency and equity 💥 Why This Episode Matters: PBM dominance is no longer just a pharmacy issue—it’s an economic justice issue. This episode sheds light on the structural forces keeping drug prices high and independent pharmacies on the edge. It offers a compelling call to action for healthcare professionals, lawmakers, and reform advocates to push back against monopolistic control and put patients first. 📢 Call to Action: Visit www.economicliberties.us to explore their policy work and toolkits for reform advocates. Stay tuned to the PBM Reform Podcast as we bring together voices from across the healthcare and policy spectrum to fight for a fairer, more transparent system. Follow, rate, and share the podcast—because real reform starts with awareness and ends with action.

In this high-impact episode, Todd Eury leads a grounded and insightful discussion about smarter pharmacy purchasing in one of the most challenging business climates pharmacy has ever faced. Joined by Josh Miller of HAC Pharmacies and SureCost founder Calvin Hunsicker, the conversation reveals both the pain points and the real-world solutions driving meaningful change for pharmacy leaders. Josh shares how managing procurement for 24 pharmacy locations used to mean hours of manual price comparisons and reactive decisions. That changed when his team adopted SureCost—resulting in over $200,000 in savings every four months. Josh walks listeners through the implementation journey, staff adoption, and the purchasing tools that now empower his team to make confident, data-driven decisions. Calvin brings industry-wide context with findings from the 2025 Smarter Purchasing Report, highlighting stubborn inefficiencies in pharmacy procurement and why so many organizations still rely on outdated processes. He unpacks key data trends, the surprising insights from this year’s report, and what leaders can take away to begin transforming their own operations. This episode is more than a success story—it’s a strategic playbook for pharmacy operators who are ready to lead through disruption, adapt to pricing volatility, and take back control of their margins. 💡 Key Takeaways: Manual purchasing processes are costing pharmacies more than they realize. Centralized tools like SureCost drive savings, streamline decisions, and improve visibility. Leadership mindset—not just tools—is what separates the thriving from the stagnant. 📥 Download the Report & Join the Movement: Visit SureCost.com to access the full 2025 Smarter Purchasing Report and learn more about the SureCost Insights Conference, coming this November. Make the smarter move—your margins depend on it.

In this thought-provoking episode of RxGenius, host Dr. Ryan Paul Liabenow sits down with Nadia Archambault, PharmD—a pharmacist, certified sexual health therapist, and trailblazing entrepreneur—to unpack the often-misunderstood topic of sexual health. Together, they explore why sexual health is far more than just STI prevention and reproductive function. The conversation dives deep into the psychological, emotional, and relational components of sexuality, highlighting how pharmacists and healthcare professionals can better recognize and support the full spectrum of patient needs. Nadia shares her perspective on common misconceptions, the stigma surrounding sexual well-being, and the importance of approaching patient care with sensitivity, curiosity, and respect for diverse experiences. This episode challenges traditional views and emphasizes the essential role sexual health plays in overall well-being. Key Topics Covered: Redefining sexual health beyond disease prevention The mental and emotional dimensions of sexual well-being Pharmacists' roles in normalizing and supporting sexual health conversations Addressing stigma and tailoring care to diverse identities and needs Nadia’s journey from pharmacist to sexual health advocate and entrepreneur Tune in to RxGenius for an open, insightful dialogue that will reshape how you think about sexual health in pharmacy and patient care.

Today I got to have an amazing conversation that busts myths and makes the road to recovery seem simple and in one’s reach. My guest’s message is that you can solve even complex health problems with a systematic and proven step by step approach. Mel Hopper Koppelman, Program Director at Synthesis Health Lab, is the go-to expert for people who've "tried everything" to heal their chronic illness but keep hitting dead ends. By guiding her patients through a systematic 5 Stage Process, she helps patients achieve a 50%+ reduction in symptoms without endless supplements or constant lab testing. With two master's degrees and 15 years of clinical experience, Mel has pioneered a revolutionary approach that combines Chinese medicine, functional medicine, and developmental neurology. Her methods have helped thousands of patients recover from conditions like chronic fatigue, autoimmune disorders, and fibromyalgia when conventional and functional medicine failed. In a world where chronic illness is skyrocketing and patients spend thousands on supplements and lab tests without getting better, Mel is passionate about providing relief. Instead of chasing symptoms and over-focusing on lab markers, she helps people understand the first principles of healing and repair their nervous system's foundation. Her mission is transforming how we approach chronic illness by bridging the gap between ancient wisdom and modern neuroscience. Connect with Mel via: Email: melhk@fastmail.com  Website: https://synthesishealth.co/shl FB: Mel Hopper Koppelman IG: @synthesishealth.co Linked In: Mel Hopper Koppelman Listeners can apply to be a free Guest in the Synthesis Health Solutions and Support Group. They can find the application at https://synthesishealth.co/shl

Check out the full episode with bonus insights: https://masterthemargin.substack.com/p/one-big-beautiful-bill-what-the-new Schedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/ More resources about this topic: Podcast - Master The Margin: 2025 Tax Outlook: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-2025-outlook/ Webinar - Tax Cuts and Jobs Act of 2017: Pharmacy Impact and §199A: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-of-2017-pharmacy-impact-and-%c2%a7199a/ Blog – Tax-smart Depreciation on Pharmacy Buildings and Equipment: https://www.sykes-cpa.com/tax-smart-depreciation-on-pharmacy-buildings-and-equipment/ Blog – Maximize Pharmacy State and Local Tax Deductions (SALT): https://www.sykes-cpa.com/maximize-pharmacy-state-and-local-tax-deductions-salt/  

Dr. William Soliman is the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is America’s leader in life sciences accreditation, certification & training.  Soliman is a former pharmaceutical executive who worked in leadership roles at Merck, Abbvie, Gilead and more. He is considered a pharma industry futurist and has been featured on NewsNation, Fox News, Newsmax, Forbes, Al Jazeera, Yahoo Business TV, ABC News Radio & more. The ACMA established the first ever certification standards in the United States and stands as a benchmark of excellence for prior authorization professionals, reimbursement professionals, pharmaceutical sales professionals, medical science liaisons and medical affairs professionals.  Dr. Soliman received his PhD from Columbia University & his BA from New York University.

In this special episode of FrameworkFocus, we’re getting you ready for the 2025 FrameworkLTC Innovation Conference—Where LTC Pharmacy Connects. You might remember it as our “User Conference,” but we’ve refreshed the name to better reflect where we’re headed. This event has always been about more than just software; it’s about accelerating innovation, sharing ideas, and shaping the future of Long-Term Care Pharmacy. Tune in as we highlight what’s new for this year, what attendees can expect, and why this event continues to be a must-attend gathering. Plus, hear from Matthew Gilbert, VP of Business Transformation and Major Accounts at RxSafe, Diamond sponsor this year, who shares insights from a vendor perspective and discusses why RxSafe is excited to participate in this year’s conference.

Join us as we celebrate 10 years of biosimilars. In this episode of The Counter Talk™ Podcast host Jason Callori speaks with Dracey Poore, Director of Biosimilars at Cardinal Halth to discuss the evolution of biosimilars and their impact on the healthcare landscape. Dracey shares valuable information on it's importance within the market and role of pharmacists. Click here to download the report and learn more. DOWNLOAD

Join obesity experts, Dr Robert Kushner, Rameck Hunt, and Michael Knight, as they discuss the impact of social determinants of health (SDOH) on patients with obesity. • Robert Kushner, MD • Rameck Hunt, MD • Michael Knight, MD This podcast is sponsored by Novo Nordisk and is intended for healthcare professionals.

Panelists: Scott Wittnebel – Director of Pharmacy Services, IPC Mark Kinney – Executive Vice President of Government Relations, IPC Sam Pomeroy – Director of Pharmacy Services and Specialty Programs, IPC Nick Secrest – Vice President of Member Performance, IPC​ Visit www.ipcrx.com to learn more about IPC's services